
Asia Pacific hemodynamic monitoring systems market will grow by 8.0% annually with a total addressable market cap of $4,242.7 million over 2022-2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic.
Highlighted with 28 tables and 41 figures, this 105-page report 鈥淎sia Pacific Hemodynamic Monitoring Systems 麻豆原创 2021-2031 by Component (Catheters, Sensors, Monitoring Devices, Probes, Others), Modality (Invasive, Minimally Invasive, Non-Invasive), Setting (Hospitals, Clinics, Ambulatory Care Units, 麻豆原创care, Others), and Country: Trend Forecast and Growth Opportunity鈥 is based on a comprehensive research of the entire Asia Pacific hemodynamic monitoring systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥 麻豆原创 Structure
鈥 Growth Drivers
鈥 Restraints and Challenges
鈥 Emerging Product Trends & 麻豆原创 Opportunities
鈥 Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific hemodynamic monitoring systems market in every aspect of the classification from perspectives of Component, Modality, Setting, and Country.
Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥 Catheters
鈥 Sensors
鈥 Monitoring Devices
鈥 Probes
鈥 Other Components
Based on Modality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥 Invasive Monitoring
鈥 Minimally Invasive Monitoring
鈥 Non-Invasive Monitoring
By Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥 Hospitals
鈥 Clinics
鈥 Ambulatory Care Units
鈥 麻豆原创care
鈥 Other Settings
Geographically, the following national/local markets are fully investigated:
鈥 Japan
鈥 China
鈥 South Korea
鈥 Australia
鈥 India
鈥 Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Modality, and Setting over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Baxter International Inc.
Caretaker, LLC
Cheetah Medical Inc.
CN Systems Medizintechnik GmbH
Deltex Medical Group PLC
Dragerwerk AG & Co. KGaA
Edwards Lifesciences Corporation
Flosonics Medical
GE Healthcare
Getinge Group
Heart Kinetics
ICU Medical Inc.
Koninklijke Philips N.V.
Lidco Group PLC
Masimo Corporation
NI Medical Ltd.
Osypka Medical GmbH
Retia Medical
Schwarzer Cardiotek
Sramek BioDynamics Inc.
Uscom Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 18
2.1 麻豆原创 Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 32
2.4 Emerging Opportunities and 麻豆原创 Trends 35
2.5 Porter鈥檚 Fiver Forces Analysis 39
3 Segmentation of Asia Pacific 麻豆原创 by Component 43
3.1 麻豆原创 Overview by Component 43
3.2 Catheters 45
3.3 Sensors 46
3.4 Monitoring Devices 47
3.5 Probes 48
3.6 Other Components 49
4 Segmentation of Asia Pacific 麻豆原创 by Modality 50
4.1 麻豆原创 Overview by Modality 50
4.2 Invasive Monitoring 52
4.3 Minimally Invasive Monitoring 53
4.4 Non-Invasive Monitoring 54
5 Segmentation of Asia Pacific 麻豆原创 by Setting 55
5.1 麻豆原创 Overview by Setting 55
5.2 Hospitals 57
5.3 Clinics 58
5.4 Ambulatory Care Units 59
5.5 麻豆原创care 60
5.6 Other Settings 61
6 Asia-Pacific 麻豆原创 2021-2031 by Country 62
6.1 Overview of Asia-Pacific 麻豆原创 62
6.2 Japan 65
6.3 China 68
6.4 Australia 71
6.5 India 73
6.6 South Korea 75
6.7 Rest of APAC Region 77
7 Competitive Landscape 79
7.1 Overview of Key Vendors 79
7.2 New Product Launch, Partnership, Investment, and M&A 82
7.3 Company Profiles 83
Baxter International Inc. 83
Caretaker, LLC 85
Cheetah Medical Inc. 86
CN Systems Medizintechnik GmbH 87
Deltex Medical Group PLC 88
Dragerwerk AG & Co. KGaA 89
Edwards Lifesciences Corporation 90
Flosonics Medical 91
GE Healthcare 92
Getinge Group 93
Heart Kinetics 94
ICU Medical Inc. 95
Koninklijke Philips N.V. 96
Lidco Group PLC 97
Masimo Corporation 98
NI Medical Ltd. 99
Osypka Medical GmbH 100
Retia Medical 101
Schwarzer Cardiotek 102
Sramek BioDynamics Inc. 103
Uscom Ltd. 104
RELATED REPORTS 105
Selected Key Players:
Baxter International Inc.
Caretaker, LLC
Cheetah Medical Inc.
CN Systems Medizintechnik GmbH
Deltex Medical Group PLC
Dragerwerk AG & Co. KGaA
Edwards Lifesciences Corporation
Flosonics Medical
GE Healthcare
Getinge Group
Heart Kinetics
ICU Medical Inc.
Koninklijke Philips N.V.
Lidco Group PLC
Masimo Corporation
NI Medical Ltd.
Osypka Medical GmbH
Retia Medical
Schwarzer Cardiotek
Sramek BioDynamics Inc.
Uscom Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.
